PSUR (Periodic Safety Update Report) Services*
Integrated periodic safety update report services based on
validated data, continuous monitoring, and inspection-ready
regulatory documentation.
validated data, continuous monitoring, and inspection-ready
regulatory documentation.
*PSUR in PBRER format
PSURs in Ongoing Benefit–Risk Evaluation
Aggregates global safety data, evaluates cumulative adverse events, monitors literature, and assesses benefit–risk balance. Each PSUR or periodic safety update report ensures traceable decision-making, regulatory alignment, and long-term management of the safety profile.
Our Periodic Safety Update Report Services
Our Periodic Safety Update Report (PSUR) services integrate data analysis, literature
monitoring, and structured benefit-risk evaluation for worldwide regulatory compliance, upholding product safety oversight.
monitoring, and structured benefit-risk evaluation for worldwide regulatory compliance, upholding product safety oversight.
End-to-end PSUR authoring
We develop complete PSURs , consolidating global safety data, performing medical review, and producing reports that reflect comprehensive benefit–risk assessments.
PSUR refresh/update
We make sure that all information is up to date and in line with regulatory requirements by updating existing PSURs with new case data, literature, and signals.
PSUR review and remediation
To ensure complete regulatory compliance and an open safety assessment, our team audits PSURs, finds any gaps or
inconsistencies, and corrects reports.
inconsistencies, and corrects reports.
PSUR submission support
We assist with PSUR submissions, coordinating filing,
formatting, and authority communication to ensure
inspection-ready outputs.
formatting, and authority communication to ensure
inspection-ready outputs.
Does this sound like a solution that could help your team right now?
We invite you to experience the benefits of DrugCard with a free 2-week trial.
PSUR Deliverables Built for Review and Submission
- Complete PSURs with benefit–risk evaluation
- Consolidated global safety data and literature monitoring
- Updated case reports and signal analysis
- Transparent medical review and regulatory alignment
- Audit-ready formatting and submission support
- Consistent reporting across the product lifecycle and regions
How we work
1
Kick-off: Work with MAHs or CROs to coordinate objectives, timelines, and legal requirements in order to establish reporting scope and deliverables.
2
Data collection and reconciliation: gather safety data, fix discrepancies, and ensure accurate, traceable datasets.
3
Medical writing: draft PSURs with integrated safety analysis, benefit-risk evaluation, signal detection, and regulatory-compliant narratives.
4
Review cycle management: to maintain version control, apply changes, monitor changes, and coordinate MAH/CRO input.
5
Finalization and handover: generate reports that are ready for inspection, provide finished
paperwork, and assist with any additional
questions or clarifications.
paperwork, and assist with any additional
questions or clarifications.
Data Inputs We Typically Use for PSUR Preparation
Literature searches, pharmacovigilance systems, safety summaries, case reports from
clinical trials, post-marketing surveillance studies, signal management outputs, and
communication with regulatory authorities. All these inputs are integrated, validated, and organized for effective preparation of PSURs.
clinical trials, post-marketing surveillance studies, signal management outputs, and
communication with regulatory authorities. All these inputs are integrated, validated, and organized for effective preparation of PSURs.
Timelines and What We Need From You
- Explicit project start dates and due dates for reports
- Availability of pharmacovigilance and clinical datasets
- Submission frequency of case studies, research updates, and literature reviews
- Timely feedback during review cycles to keep the schedule on track
- Information on regulatory expectations and regional requirements
- Provision of critical applicant information for inspection-ready submissions
Common PSUR Issues We Fix
Many companies struggle with the same recurring challenges in PSUR preparation and submission. Our team identifies and resolves the most frequent issues, including:
- Incomplete or inconsistent adverse event data across reporting periods
- Gaps in literature monitoring coverage or documentation
- Misalignment between safety data and benefit–risk conclusions
- Non-compliance with regional regulatory formatting requirements
- Delayed submissions due to poor version control or review cycle management
- Inadequate signal detection documentation and follow-up
Engagement Options We Provide
Comprehensive PSUR services, targeted review and remediation, program support across multiple products or regions, and authority query assistance — flexible engagement
models that let customers choose support based on regulatory requirements and project scope.
models that let customers choose support based on regulatory requirements and project scope.
Why Choose DrugCard for a Partnership
DrugCard offers assured PSUR services, which are regulatory compliant, inspection-ready, and supported by a smooth review cycle. Customers benefit from full traceability,
consistent quality, and assured safety data integrity across the entire product lifecycle.
consistent quality, and assured safety data integrity across the entire product lifecycle.
Our Case Studies
January 26, 2026
No Comments
January 26, 2026
No Comments
Have a question? Just fill out the form and we will contact you within 60 min
- Book a meeting for the demonstraion
- Anwers your additional questions
- Implenetation DrugCard to your pharmacovigilance system
- Tariff plans, pricing, addional features